COVID-19: combining antiviral and anti-inflammatory treatments
Clicks: 242
ID: 266552
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
7.5
/100
25 views
25 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
COVID-19: combining antiviral and anti-inflammatory treatments
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (6 words).
Try re-searching for a better abstract.
| Reference Key |
j2020thecovid-19:
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Stebbing J;Phelan A;Griffin I;Tucker C;Oechsle O;Smith D;Richardson P;; |
| Journal | The Lancet. Infectious Diseases |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
covid-19
sars-cov-2
pubmed abstract
nih
national institutes of health
national library of medicine
pandemics
Viral
comment
pneumonia
betacoronavirus
anti-inflammatory agents
coronavirus infections / drug therapy
antiviral agents*
peter richardson
justin stebbing
pmid:32113509
pmc7158903
doi:10.1016/s1473-3099(20)30132-8
anne phelan
azetidines
sulfonamides
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.